BIOLASE, Inc. (BIOL)
Stock Price Chart
Key Info
| Market Cap | 23.97M |
| Revenue (ttm) | 26.55M |
| Net Income (ttm) | -19.77M |
| Shares Out | 92.19M |
| EPS (ttm) | -0.67 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Oct 30, 2020 |
| Last Price | $0.260 |
| Previous Close | $0.273 |
| Change ($) | -0.013 |
| Change (%) | -4.87% |
| Day's Open | 0.268 |
| Day's Range | 0.260 - 0.273 |
| Day's Volume | 1,238,148 |
| 52-Week Range | 0.211 - 0.960 |
More Stats
| Market Cap | 23.97M |
| Enterprise Value | 34.90M |
| Earnings Date (est) | Nov 4, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 92.19M |
| Float | 84.80M |
| EPS (basic) | -0.67 |
| EPS (diluted) | -0.67 |
| FCF / Share | -0.41 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 327,327 |
| Short Ratio | 0.14 |
| Short % of Float | 0.39% |
| Beta | 1.84 |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | 0.90 |
| PB Ratio | 21.97 |
| Revenue | 26.55M |
| Operating Income | -17.26M |
| Net Income | -19.77M |
| Free Cash Flow | -15.62M |
| Net Cash | -10.94M |
| Net Cash / Share | -0.12 |
| Gross Margin | 53.82% |
| Operating Margin | -65.02% |
| Profit Margin | -74.50% |
| FCF Margin | -58.84% |
| ROA | -35.87% |
| ROE | -774.75% |
| ROIC | -122.30% |
Analyst Forecasts
Analyst Consensus: Buy
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 37.80 | 46.16 | 46.93 | 51.81 | 48.48 | 47.66 | 56.43 | 57.36 | 48.86 | 26.23 |
| Revenue Growth | -18.1% | -1.64% | -9.43% | 6.88% | 1.72% | -15.55% | -1.61% | 17.39% | 86.3% | - |
| Gross Profit | 14.29 | 16.90 | 15.13 | 20.31 | 15.95 | 18.17 | 21.53 | 26.48 | 21.32 | 8.83 |
| Operating Income | -15.62 | -20.89 | -18.04 | -14.96 | -19.92 | -17.94 | -11.00 | -2.53 | -4.00 | -11.50 |
| Net Income | -17.86 | -21.52 | -16.85 | -15.37 | -20.28 | -18.93 | -11.48 | -3.06 | -4.49 | -12.02 |
| Shares Outstanding | 23.20 | 20.59 | 14.75 | 12.13 | 11.64 | 8.45 | 6.55 | 6.43 | 6.12 | 5.36 |
| Earnings Per Share | -0.77 | -1.05 | -1.41 | -1.45 | -1.75 | -2.25 | -1.75 | -0.50 | -0.75 | -2.26 |
| Operating Cash Flow | -12.75 | -14.15 | -18.41 | -10.60 | -17.77 | -16.20 | -9.30 | -1.66 | -13.32 | -3.81 |
| Capital Expenditures | -0.21 | -0.52 | -0.75 | -1.41 | -1.78 | -0.20 | -0.68 | -0.68 | -0.43 | -0.24 |
| Free Cash Flow | -12.95 | -14.67 | -19.16 | -12.01 | -19.55 | -16.40 | -9.97 | -2.35 | -13.75 | -4.05 |
| Cash & Equivalents | 6.10 | 8.36 | 11.90 | 9.18 | 11.90 | 31.56 | 1.44 | 2.54 | 3.31 | 1.69 |
| Total Debt | 13.47 | 10.84 | - | - | 0.16 | - | 4.63 | 1.64 | - | 2.62 |
| Net Cash / Debt | -7.37 | -2.48 | 11.90 | 9.18 | 11.74 | 31.56 | -3.19 | 0.91 | 3.31 | -0.93 |
| Assets | 31.85 | 38.52 | 42.98 | 41.94 | 42.25 | 59.40 | 31.04 | 31.97 | 29.81 | 18.15 |
| Liabilities | 27.51 | 27.43 | 13.72 | 19.88 | 17.33 | 17.35 | 22.56 | 20.18 | 17.24 | 21.19 |
| Book Value | 0.38 | 11.09 | 29.26 | 22.07 | 24.93 | 42.06 | 8.48 | 11.79 | 12.57 | -3.05 |
Company Profile
Company Details
| Full Name | BIOLASE, Inc. |
| Country | United States |
| Employees | 157 |
| CEO | Todd A. Norbe |
Stock Information
| Ticker Symbol | BIOL |
| Stock Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Unique Identifier | NASDAQ: BIOL |
| IPO Date | November 13, 1992 |
Description
BIOLASE, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode laser systems to perform soft tissue, hygiene, cosmetic procedures, and teeth whitening, as well as to provide temporary pain relief; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Irvine, California.